Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Eutro ( EUTO ) -- Ignore unavailable to you. Want to Upgrade?

To: ALL IN PAUL who wrote (1915)	12/1/1997 4:15:00 AM
From: Dale Jay	Respond to of 12043

To Alan and Laron: Looking forward to hearing back on your reporting after you have spoken to Brad. Apart from the retirement of the shares, would also like an update on current projects/investments. Guess there is no point in too many of us calling if you can get the information and report back timely. Thanks for your efforts and also looking forward to good things for EUTO into the Christmas holidays and beyond.

To: ALL IN PAUL who wrote (1915)	12/1/1997 12:47:00 PM
From: ALL IN PAUL	Read Replies (3) \| Respond to of 12043

There are 4 components to getting this squeeze done. It takes time and will (IMO) take additional time to have all of the bases covered. After my discussion with Brad today, I believe the following numbers describe our situation: 100M # common shares EUTRO is authorized (actual # issued may be 98M) -50M # shares "in escrow" (Brad's words) (component #1) ---- 50.0M -26.8M # of common shares to be retired. (80% of 33.5M=26.8M) (#2) ------ 23.2M -10.0M <-- approx # shares held by insiders (#3) ------ 13.2M <-- # shares in the float not held by insiders. (#4) Now for the 4 potential issues... Issue #1) The 50M held "in escrow". These need to be in cert form for the squeeze to work. I need to call again to followup on this point, but, before doing so, will wait for a report from Alan. Alan, you are calling Brad today, right? Issue #2) Brad and I worked through the retired shares story. He verified that a total of 33.5M shares of common stock was sent to be processed according to the deal offered in July/Aug. As he pointed out (something I realized last night reviewing the posts and press releases), the deal called for 80% of the submitted shares to be retired in exchange for preferred shares and warrants. That's why 26.8M is to be retired instead of 33.5M. Having said that, he noted that the TA still reports 85M has being issued and outstanding, a number that Brad called, "inaccurate". The TA should be reporting 100M-26.8M=73.2M. It has been posted many times before and it still rings true, the TA NEEDS TO PROCESS ALL THE CONVERTED SHARES FOR THIS TO WORK. By my numbers, the TA needs to retire another 85-73.2=11.8M shares. That is 11.8M SHARES WORKING AGAINST US UNTIL THE TA GETS THE JOB DONE!!! Issue #3) Brad said that "approximately 10M" shares are held by insiders. Obviously the fewer shares held by them, the more shares we need. The issue here is that I'd prefer a more thorough accounting of these 10M shares. Issue #4) This will be the MM's issue as I know that the public has well over 13.2M shares in hand. From my point of view, the biggest concern is getting the TA to retire those remaining shares. This is the only issue that the company and shareholders must depend on someone outside to resolve. The company wants to see shareholder value rise, so the other items are not a concern, IMHO. The biggest problem remains the TA. Having said that, I would like to see progress on the 50M in cert form and a better accounting of insider shares. Looking forward to Alan's summary of discussion with Brad. GO EUTO GO !!! Laron P.

To: ALL IN PAUL who wrote (1915)	12/1/1997 12:55:00 PM
From: ALL IN PAUL	Respond to of 12043

Additional comments from my discussion with Brad. Someone asked me to verify the status of contracts, so here goes... Brad said that the Bio-Analytics is the only, active subsidiary at this moment. From the press releases I believe Bio to be doing better than expected. The two current contracts are Santiago and Freedom Medical. Progress is being made on the work related to these contracts. Additionally, negotiations on 2 other contracts continues. No promises to have anything signed before the end of this year. Note that Eutro's fiscal year starts with October (they align their year with Bio since that is the only active subsidiary). So, signing a deal by the end of the year is not nearly as important to Eutro as it would be to most companies which have their fiscal years end in December (IMO). Hope this helped whoever asked... GO EUTO GO !!! Laron P.